Covaxin

Covaxin is now a universal vaccine against Covid-19 for adults and children: Bharat Biotech

Covaxin is now a universal vaccine against Covid-19 for adults and children: Bharat Biotech

New Delhi: In another milestone in India’s vaccination feat, a locally developed vaccine against the coronavirus – Covaxin – has now been recognized “around the world” as a “universal vaccine for adults and children”. “COVAXIN is now a universal vaccine for adults and children. Our goals of developing a global vaccine against COVID-19 have been …

Covaxin is now a universal vaccine against Covid-19 for adults and children: Bharat Biotech Read More »

Delhi no longer has Covishields; Maharashtra, MP also complains of vaccine shortage

New Delhi: Several states, including the national capital Delhi, Odisha, and Madhya Pradesh, have reported a shortage of vaccines against Covid-19. Deputy Chief Minister Manish Sisodia informed that several government-run vaccination centers in Delhi will be closed on Tuesday as the city ran out of its stock of Covishield COVID-19 vaccines. While sharing a report …

Delhi no longer has Covishields; Maharashtra, MP also complains of vaccine shortage Read More »

Find out how many countries have approved the Covishield vaccine so far – Check out the list here

New Delhi: Five vaccines have been approved in India, including Covaxin, Covishield, Sputnik V, Moderna, Johnson & Johnson’s Single Dose Vaccine, and the Zydus Cadila vaccine – ZyCoV-D. Among the vaccines administered in India, the Covishield vaccine is administered in the largest number. This vaccine was developed by Oxford-AstraZeneca together. In India, it is produced …

Find out how many countries have approved the Covishield vaccine so far – Check out the list here Read More »

CDSCO Expert Panel recommends emergency use of Covaxin for children aged 2-18

New Delhi: The CDSCO (Central Medicines Standards Control Organization) expert committee has approved the administration of Covaxin to children between the ages of 2 and 18, according to official sources. After a meeting yesterday, the SEC sent its recommendation to the Drug Controller General of India for approval. Phase II and III trials were conducted …

CDSCO Expert Panel recommends emergency use of Covaxin for children aged 2-18 Read More »

AIIMS Delhi to start Recruiting tomorrow for a clinical trial of the Covaxin in children aged 6 to 12

New Delhi: The Indian Institute of Medical Sciences (AIIMS) in Delhi is about to start recruiting for clinical trials of the Covaxin vaccine in children aged 6 to 12. There are reports that recruitment for the clinical trial of the first locally developed COVID-19 vaccine in children will begin on Tuesday, June 15. This will …

AIIMS Delhi to start Recruiting tomorrow for a clinical trial of the Covaxin in children aged 6 to 12 Read More »

IIL is ready to roll out Bharat Biotech’s Covaxin drug substance by July-August

Indian Immunological Limited (IIL) is a name that may have been heard by some outside the vaccine industry. But the vaccine manufacturer hopes to play an important role in Bharat Biotech’s ambitious plan, which will increase production of covaxin to 700 million doses annually. IIL executive officers are overdue to revive the newly built manufacturing …

IIL is ready to roll out Bharat Biotech’s Covaxin drug substance by July-August Read More »

Omicron Variant: Will virus mutations make vaccines ineffective? Here's what ICMR's Senior Scientist said

Omicron Variant: Will virus mutations make vaccines ineffective? Here’s what ICMR’s Senior Scientist said

New Delhi: Indian Council of Medical Research (ICMR) scientist Samiran Panda on Saturday addressed concerns about Omicron Variant by saying that genomic variations and structural changes have been reported in other countries in the new variant of the coronavirus, but whether these would lead to increased transmission or make ineffective vaccines is under consideration. The …

Omicron Variant: Will virus mutations make vaccines ineffective? Here’s what ICMR’s Senior Scientist said Read More »

Bharat Biotech joins MoU and GCVC to produce Covaxin drug product

Bharat Biotech on May 27 signed a MoU with the Gujarat Covid Vaccine Consortium (GCVC) to contract a drug product Covaxin. The Gujarat Covid Vaccine Consortium (GCVC) contains Hester Biosciences, the Gujarat Biotechnology Research Center (GBRC), the Gujarat Government and Omnibrx Biotechnologies. According to the MoU, Bharat Biotech will provide Covaxin drug production technology. The …

Bharat Biotech joins MoU and GCVC to produce Covaxin drug product Read More »

Decision On WHO Emergency Approval For Covaxin Postponed To Next Week

New Delhi: The World Health Organization (WHO) will take the long-awaited decision on the submission of Hyderabad-based vaccine manufacturer Bharat Biotech requesting an Emergency Use List (EUL) for its Covid-19 vaccine Covaxin the next week. “WHO and a group of independent experts are to meet next week to conduct the risk/benefit assessment and make the …

Decision On WHO Emergency Approval For Covaxin Postponed To Next Week Read More »

Delta OR Delta Plus: which vaccines are effective against new variants of Covid-19

Be it Delta or Delta Plus, none of the variants can pierce the mask, Niti Aayog member (health) VK Paul said. The World Health Organization recently expressed concerns that the Delta variant of Covid-19, the variant first detected in India, was reducing the effectiveness of existing Covid-19 vaccines around the world. A new mutant of …

Delta OR Delta Plus: which vaccines are effective against new variants of Covid-19 Read More »

Scroll to Top